Position
Chief Financial Officer
Company
Apimeds Pharmaceuticals US
MatawanBiotechnologyHealth CareTherapeuticsBiopharmaDescription
On September 30, 2026, Apimeds Pharmaceuticals US, Inc. appointed Eric Sherb as Chief Financial Officer, effective October 1, 2026. This appointment follows the resignation of Erik Frim as Interim Chief Financial Officer
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
- Altimmune Appoints Richard Menziuso as Vice President, Global Controller (September 29, 2026)
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
- ABIVAX Appoints New Chief Medical Officer and Chief Technical Officer (September 26, 2026)
- Jazz Pharmaceuticals Announces Transition in Leadership (October 9, 2026)
- Fate Therapeutics Appoints Jamie Harrell as Chief Commercial Officer (October 12, 2026)
Who to call at Apimeds Pharmaceuticals US, and when
A new leader at Apimeds Pharmaceuticals US brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Apimeds Pharmaceuticals US raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Apimeds Pharmaceuticals US, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Apimeds Pharmaceuticals US. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Apimeds Pharmaceuticals US changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Apimeds Pharmaceuticals US changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.